GSK Price Chart
Loading chart...
50 DMA150 DMA200 DMA
GSKGSK plc
$49.90
Financials
NEUTRAL
Investment Thesis
GSK is neither a clear buy nor avoid. RS 73/99, strong earnings. keep it on your radar.
Mixed signals = No edge currently
Key Takeaways
- Earnings strong
- RS 73 - needs improvement
- Wait & watch
Earnings Momentum
Earnings Accelerating
Price Structure
Aligned UptrendPrice
$49.90
✓→
50 DMA
$48.31
✓→
100 DMA
$45.14
✓→
150 DMA
$42.93
✓→
200 DMA
$41.66
Alignment Score: 4/4✓ Confirmed Uptrend
Why Not BUY Yet?
RS Rating
73 (Top 27%)→>80 (Top 20%)
Pattern Stage
AT_PIVOT→At pivot or near breakout
What Would Change Our Mind?
To turn bullish on GSK, we need:
- RS Rating: >80 (Top 20%)(currently 73 (Top 27%))
- Pattern Stage: At pivot or near breakout(currently AT_PIVOT)
Twin Engines Dashboard
Technical Health
RS Rating
73/99
Top 27% (Need 80+)
Trend
Aligned Uptrend
Above 200 DMA
RSI (14)
63
BULLISH
VCP Setup
COOL
Score: 5/9
Volume
3.7M
-3% vs avg
From Entry
+3.1%
$48.41
Fundamental Horsepower
EPS Qtr YoY
+202%
Accelerating
EPS 3Y CAGR
-23%
Annual Earnings
Revenue Qtr
+7%
WEAK
F-Score
5/9
Piotroski Quality
ROE
18%
Return on Equity
EPS Rank
97/99
Percentile
Trade Plan
Stalled BreakoutBreakout Date2025-11-1165 days ago
Entry Was$48.41Breakout price
Gain Since+3%From entry
Reclaim$49.4121 EMA support
If/Then Playbook
IF: RS Rating improves to >80
THEN: Re-evaluate for potential
IF: EPS growth accelerates next quarter
THEN: Check for developing setup
IF: VCP pattern begins forming
THEN: Add to watchlist if RS also improving
IF: Price breaks below 200 DMA
THEN: Remove from radar
Key Price Levels
Resistance
- 52W High$51.46+3.1%
- Pivot$51.46+3.1%
Current$49.90
Support
- 20 DMA$49.39-1.0%
- 50 DMA$48.31-3.2%
- 200 DMA$41.66-16.5%
More GSK Analysis
Frequently Asked Questions
Is GSK stock a buy now?
GSK is neither a clear buy nor avoid. RS 73/99, strong earnings. keep it on your radar.
What is the buy point for GSK?
GSK broke out at $48.41 2 month(s) ago but has stalled (+3%). Wait for fresh momentum or new base pattern.
What is GSK's RS Rating?
GSK has an RS Rating of 73/99, meaning it's in the Top 27% of all stocks for relative price performance over the past 12 months. Minervini recommends RS 80+ for momentum trades.
Important Disclosure: This analysis is for educational and informational purposes only. Technical and fundamental indicators are based on historical data and do not guarantee future performance. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.